Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung

M. Worm; A. Bauer; B. Wedi; R. Treudler; W. Pfuetzner; K. Brockow; T. Buhl; T. Zuberbier; J. Fluhr; G. Wurpts; L. Klimek; T. Jacob; H. F. Merk; N. Mülleneisen; S. Roeseler; H. Dickel; U. Raap; J. Kleine-Tebbe

doi:10.5414/ALX02225

Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung

Translated title of the contribution: Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - A harmonized statement of allergy centers in Germany

M. Worm
, A. Bauer
, B. Wedi
, R. Treudler
, W. Pfuetzner
, K. Brockow
, T. Buhl
, T. Zuberbier
, J. Fluhr
, G. Wurpts
, L. Klimek
, T. Jacob
, H. F. Merk
, N. Mülleneisen
, S. Roeseler
, H. Dickel
, U. Raap
, J. Kleine-Tebbe

Department of Dermatology and Allergology

Charité – Universitätsmedizin Berlin
Universitätsklinikum Carl Gustav Carus Dresden
Hannover Medical School
Universitätsmedizin Leipzig
Somnomar Institut für Medizinische Forschung und Schlafmedizin
University Medical Center
University Hospital
Universitätsmedizin Mannheim
Universitätsklinikum
RWTH Aachen University
Asthma- und Allergiezentrum
University of Cologne
Huntington-Zentrum (NRW) Bochum im St. Josef Hospital
Universität Oldenburg
Allergie- und Asthma-Zentrum Westend

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie. net using an online questionnaire.

Translated title of the contribution	Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - A harmonized statement of allergy centers in Germany
Original language	German
Pages (from-to)	95-99
Number of pages	5
Journal	Allergologie
Volume	44
Issue number	2
DOIs	https://doi.org/10.5414/ALX02225
State	Published - Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.5414/ALX02225

Cite this

Worm, M., Bauer, A., Wedi, B., Treudler, R., Pfuetzner, W., Brockow, K., Buhl, T., Zuberbier, T., Fluhr, J., Wurpts, G., Klimek, L., Jacob, T., Merk, H. F., Mülleneisen, N., Roeseler, S., Dickel, H., Raap, U., & Kleine-Tebbe, J. (2021). Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung. Allergologie, 44(2), 95-99. https://doi.org/10.5414/ALX02225

@article{022212b34fc8414db78cf82431448ee2,

title = "Praktische Empfehlungen zur allergologischen Risikoabsch{\"a}tzung der COVID-19-Impfung",

abstract = "Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie. net using an online questionnaire.",

keywords = "Allergy, Anaphylaxis, COVID-19 vaccination, Polyethylenglycol, Polysorbate 80, Skin test",

author = "M. Worm and A. Bauer and B. Wedi and R. Treudler and W. Pfuetzner and K. Brockow and T. Buhl and T. Zuberbier and J. Fluhr and G. Wurpts and L. Klimek and T. Jacob and Merk, \{H. F.\} and N. M{\"u}lleneisen and S. Roeseler and H. Dickel and U. Raap and J. Kleine-Tebbe",

note = "Publisher Copyright: {\textcopyright} 2021 Dustri-Verlag Dr. Karl Feistle",

year = "2021",

month = feb,

doi = "10.5414/ALX02225",

language = "Deutsch",

volume = "44",

pages = "95--99",

journal = "Allergologie",

issn = "0344-5062",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "2",

}

Worm, M, Bauer, A, Wedi, B, Treudler, R, Pfuetzner, W, Brockow, K, Buhl, T, Zuberbier, T, Fluhr, J, Wurpts, G, Klimek, L, Jacob, T, Merk, HF, Mülleneisen, N, Roeseler, S, Dickel, H, Raap, U & Kleine-Tebbe, J 2021, 'Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung', Allergologie, vol. 44, no. 2, pp. 95-99. https://doi.org/10.5414/ALX02225

TY - JOUR

T1 - Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung

AU - Worm, M.

AU - Bauer, A.

AU - Wedi, B.

AU - Treudler, R.

AU - Pfuetzner, W.

AU - Brockow, K.

AU - Buhl, T.

AU - Zuberbier, T.

AU - Fluhr, J.

AU - Wurpts, G.

AU - Klimek, L.

AU - Jacob, T.

AU - Merk, H. F.

AU - Mülleneisen, N.

AU - Roeseler, S.

AU - Dickel, H.

AU - Raap, U.

AU - Kleine-Tebbe, J.

PY - 2021/2

Y1 - 2021/2

N2 - Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie. net using an online questionnaire.

AB - Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie. net using an online questionnaire.

KW - Allergy

KW - Anaphylaxis

KW - COVID-19 vaccination

KW - Polyethylenglycol

KW - Polysorbate 80

KW - Skin test

UR - https://www.scopus.com/pages/publications/85101481731

U2 - 10.5414/ALX02225

DO - 10.5414/ALX02225

M3 - Artikel

AN - SCOPUS:85101481731

SN - 0344-5062

VL - 44

SP - 95

EP - 99

JO - Allergologie

JF - Allergologie

IS - 2

ER -

Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this